Vanco and ACST’s combined reach now serves more than 40,000 churches and ministries Vanco also serves K–12 districts with education payments solutions, including RevTrak and SmartCare. Joe Koehling, ...

Trusted church management provider ACS Technologies and secure payments leader Vanco come together to serve more churches with a connected, seamless experience. Together, the companies will bring ...

The Neonatal and Paediatric Pharmacists Group (NPPG) released a report which carried out a vancomycin in paediatric audit (VIPA). This report reviewed the effectiveness of currently employed ...

Guidelines recommend against use of midline catheters for vancomycin-based outpatient parenteral antimicrobial therapy (OPAT), but evidence supporting the guidance is limited. This retrospective study ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...

LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced the approval of a novel formulation of the first-of-its-kind, ready-to ...

VANCOMYCIN is a penicillinase-resistant antibiotic that may be used in the treatment of staphylococcal infections. Because it is known to be excreted chiefly through the kidneys in normal persons 1 ...

Glenmark is introducing vancomycin hydrochloride for injection, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial), which is the generic of Mylan’s Vancomycin Hydrochloride for Injection.

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new study has found. Results published in the Journal of Crohn's and Colitis ...

Introduction Patients with suspected bacterial infection frequently receive empiric, broad-spectrum antibiotics prior to pathogen identification due to the time required for bacteria to grow in ...

Staphylococcus aureus has the potential to develop durable vancomycin resistance, according to a new study. Staphylococcus aureus has the potential to develop durable vancomycin resistance, according ...